MarketPeel
Insider Trading Intelligence
Pricing
…
SL

Sv7 Impact Medicine Fund Lp

XLO
10% OWNER · XILIO THERAPEUTICS, INC. · CIK 0001780602
FILING MIX · LIFETIME56%/44%
BUYS
10
SELLS
8
TOTAL VALUE
$10.00M
COMPANIES
1
ACTIVE SINCE
Oct 2021
HOLDINGS NOW
1,613,632
AVG SELL PX
—
TRADE KIND
SHOWING 18 / 18
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Sv7 Impact Medicine Fund Lp, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+40.37%+1.30%+39.06%+39.06%—
14d1+100.00%+43.95%+2.50%+41.45%+41.45%—
30d1+100.00%+23.71%+2.96%+20.75%+20.75%—
60d1+0.00%-2.74%+3.58%-6.31%-6.31%—
90d1+0.00%-12.46%-3.20%-9.27%-9.27%—
180d1+0.00%-75.62%-5.39%-70.23%-70.23%—
1y1+0.00%-86.38%-14.95%-71.44%-71.44%—
2y1+0.00%-87.36%-6.70%-80.65%-80.65%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
XLO · 1,613,632 shares · as of Oct 26, 2021
0403,408806,8161,210,2241,613,632SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
FLOW · 10 buys / 8 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
XLO
XILIO THERAPEUTICS, INC.
SALE
9,486,166——0Oct 26, 2021Nov 3, 2021 ↗
XLO
XILIO THERAPEUTICS, INC.
SALE
2,874,595——0Oct 26, 2021Nov 3, 2021 ↗
XLO
XILIO THERAPEUTICS, INC.
SALE
2,874,595——0Oct 26, 2021Nov 3, 2021 ↗
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
302,588——1,301,132Oct 26, 2021Nov 3, 2021 ↗
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
998,544——998,544Oct 26, 2021Nov 3, 2021 ↗
XLO
XILIO THERAPEUTICS, INC.
SALE
9,486,166——0Oct 26, 2021Nov 3, 2021 ↗
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
302,588——1,301,132Oct 26, 2021Nov 3, 2021 ↗
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
998,544——998,544Oct 26, 2021Nov 3, 2021 ↗
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
302,588——1,301,132Oct 26, 2021Oct 28, 2021 ↗
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
998,544——998,544Oct 26, 2021Oct 28, 2021 ↗
XLO
XILIO THERAPEUTICS, INC.
SALE
2,874,595——0Oct 26, 2021Oct 28, 2021 ↗
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
302,588——1,301,132Oct 26, 2021Oct 28, 2021 ↗
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
998,544——998,544Oct 26, 2021Oct 28, 2021 ↗
XLO
XILIO THERAPEUTICS, INC.
SALE
2,874,595——0Oct 26, 2021Oct 28, 2021 ↗
XLO
XILIO THERAPEUTICS, INC.
SALE
9,486,166——0Oct 26, 2021Oct 28, 2021 ↗
XLO
XILIO THERAPEUTICS, INC.
SALE
9,486,166——0Oct 26, 2021Oct 28, 2021 ↗
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
312,500$16.00$5.00M1,613,632Oct 26, 2021Nov 3, 2021 ↗
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
312,500$16.00$5.00M1,613,632Oct 26, 2021Nov 3, 2021 ↗
Other insiders · XLO
Loading peer insiders…
About this filer
CIK 0001780602
ROLE
10% Owner
PRIMARY
XLO
COMPANIES
1
ACTIVE SINCE
Oct 2021
MARKETPEEL · /INSIDER/0001780602DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback